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stimulate the migration and maturation of lymphocytes.Sankar Ghosh1,3 and Michael Karin2,3
1Section of Immunobiology Furthermore, NF-B is central for the overall immune
response through its ability to activate genes coding forDepartment of Molecular Biophysics and
Biochemistry regulators of apoptosis and cell proliferation, such as
c-IAP-1, c-IAP-2, A1 (Bfl1), Bcl-XL, Fas ligand, c-myc,Howard Hughes Medical Institute
Yale University School of Medicine and cyclin D1, that are critical for apoptotic processes
(Karin and Lin, 2002).New Haven, Connecticut 06520
2 Laboratory of Gene Regulation and This long list of functions suggests that modulation
of NF-B activity and action should represent effectiveSignal Transduction
Department of Pharmacology therapeutic strategies for combating diseases such as
arthritis, asthma, or autoimmunity that result from hyper-School of Medicine
University of California, San Diego activation of otherwise beneficial immune responses.
Therefore, there is intense interest in understanding the9500 Gilman Drive
La Jolla, California 92093 regulation of this transcription factor in the context of
various diseases. A number of recent reviews have de-
scribed in detail various facets of NF-B regulation and
function (Baldwin, 2001; Ben-Neriah, 2002; Karin andThe regulation of the transcription factor NF-B activ-
ity occurs at several levels including controlled cyto- Ben-Neriah, 2000; Silverman and Maniatis, 2001). To
avoid duplicating these reviews, following a brief discus-plasmic-nuclear shuttling and modulation of its tran-
scriptional activity. A critical component in NF-B sion of the NF-B pathway, we will focus on four areas
of NF-B regulation that represent some of the mostregulation is the IB kinase (IKK) complex. This review
is focused on recent progress as well as unanswered intriguing and outstanding questions that are likely to
engage researchers in the near future.questions regarding the regulation and function of
NF-B and IKK.
NF-B Signaling Pathways
NF-B represents a group of structurally related and
Introduction evolutionarily conserved proteins, with five members in
The recognition of pathogens by innate or adaptive im- mammals: Rel (c-Rel), RelA (p65), RelB, NF-B1 (p50 and
mune receptors leads to activation of cells displaying its precursor p105), and NF-B2 (p52 and its precursor
these receptors, e.g., macrophages, dendritic cells, and p100) (reviewed in Ghosh et al., 1998). The mechanisms
lymphocytes. The signal generated by the liganded re- by which the p105 and p100 precursor proteins are pro-
ceptor is communicated to changes in gene expression cessed are not fully understood and were suggested to
leading to enhanced expression of effector molecules involve either posttranslational or cotranslational events
such as cytokines and adhesion molecules (Ghosh et al., (Karin and Ben-Neriah, 2000). What seems to be clear
1998; Zhang and Ghosh, 2001). This process depends is that while p105 processing is constitutive, the pro-
on activation of various inducible transcription factors, cessing of p100 is regulated (Xiao et al., 2001). NF-B/
among which the NF-B transcription factors play an Rel proteins can exist as homo- or heterodimers, and
evolutionarily conserved and critical role in the triggering although most NF-B dimers are activators of transcrip-
and coordination of both innate and adaptive immune tion, the p50/p50 and p52/p52 homodimers can repress
responses. The wide variety of genes regulated by the transcription of their target genes (Zhong et al.,
NF-B include those encoding cytokines (e.g., IL-1, IL-2, 2002). NF-B/Rel proteins share a highly conserved 300
IL-6, IL-12, TNF-, LT, LT, and GM-CSF), chemokines amino acid long N-terminal Rel homology domain (RHD)
(e.g., IL-8, MIP-1, MCP1, RANTES, and eotaxin), adhe- responsible for DNA binding, dimerization, and associa-
sion molecules (e.g., ICAM, VCAM, and E-selectin), tion with the IB inhibitory proteins (Ghosh et al., 1998).
acute phase proteins (e.g., SAA), and inducible effector In resting cells, most NF-B/Rel dimers are bound to
enzymes (e.g., iNOS and COX-2). In addition, it has been IBs and retained in the cytoplasm. The IBs are also
demonstrated recently that genes encoding evolution- members of a gene family that contains seven known
arily conserved antimicrobial peptides, such as  defen- mammalian members, IB, IB, IB, IB, Bcl-3, and
sins, is also regulated by NF-B (Ghosh et al., 1998; the precursor Rel proteins p100 and p105 (Ghosh et al.,
Zhang and Ghosh, 2001). NF-B also plays a role in 1998). Interestingly, p100 may serve both as an IB and
expression of genes encoding molecules important for as a specific heterodimeric partner for RelB, such that
the adaptive immune response, such as MHC proteins, its processing results in the release of p50:RelB hetero-
costimulatory molecules such as B7.1, and cytokines dimers (Solan et al., 2002). The IBs are characterized
such as IL-2, IL-12, and IFN- (Kopp and Medzhitov, by the presence of multiple ankyrin repeats, which are
1999). Additionally, some of the chemokines and cyto- protein-protein interaction domains that interact with
kines produced in response to NF-B activation can NF-B via the RHD (Ghosh et al., 1998). Nearly all NF-B
proteins have been crystallized, and their structures, as
well as those of cocrystals of NF-B with IB and IB,3 Correspondence: sankar.ghosh@yale.edu (S.G.), karinoffice@ucsd.
edu (M.K.) have been determined (Chen and Ghosh, 1999; Chen et
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al., 1998a, 1998b; Ghosh et al., 1995; Huang et al., 2001; nation, the IB proteins are rapidly degraded by the
Huxford et al., 1998; Jacobs and Harrison, 1998; Muller proteasome, thereby freeing NF-B, which then enters
et al., 1995). These structural studies revealed that the the nucleus, binds to DNA, and activates transcription.
RHD forms a unique butterfly-shaped structure that is As we will discuss later, it now appears that nuclear
composed of  strands arranged in a pattern similar to NF-B must also become posttranslationally modified
immunoglobulin domains. The structure of the IB: to be transcriptionally active, although the exact nature
NF-B complexes reveal a characteristic structure for of the modifications involved remains to be fully eluci-
the IB ankyrin repeats, where each repeat consists of dated. IKK is also involved in phosphorylation-induced
two closely packed helices followed by a loop and a tight processing of p100, resulting in the activation of p52:RelB
hairpin turn (Huxford et al., 1998; Jacobs and Harrison, dimers (Senftleben et al., 2001a). The biochemical
1998). The multiple repeats stack to form a slightly events that follow p100 phosphorylation, resulting in its
curved cylinder with the loops forming finger-like exten- processing, are yet to be described.
sions. Interestingly, the dimerization domain of the
NF-B dimers is the primary region of interaction with Cytoplasmic to Nuclear Transport of NF-B
IBs, although critical differences in the nature of the Molecules: Is This Paradigm Really True?
interactions mounted by IB and IB play crucial roles The defining characteristic of NF-B is its rapid inducibil-
in the regulation of NF-B activity (G. Ghosh, personal ity, which allows cells to respond to infectious organ-
communication). isms and stress by upregulating appropriate NF-B tar-
Cell stimulation with a variety of agonists triggers signal get genes. Since the original classical experiment of
transduction pathways that ultimately result in activation Baeuerle and Baltimore, who used a detergent to un-
of a specific IB kinase (IKK) (Karin and Ben-Neriah, 2000). mask the DNA binding activity of NF-B in the cytosol
IKK is a complex composed of three subunits: IKK of unstimulated cells, the central paradigm of NF-B
(IKK1), IKK (IKK2), and IKK (NEMO, IKKAP) (Karin and regulation has been the translocation of activated NF-B
Ben-Neriah, 2000). IKK and IKK are the catalytic sub- from the cytoplasm to the nucleus (Baeuerle and Balti-
units of the complex, sharing 52% overall sequence more, 1988). The basis for the cytoplasmic localization
identity and 65% identity in their catalytic domains. The of the inactive NF-B:IB complex is thought to be due
third subunit, IKK/NEMO, is the regulatory subunit and to masking of the nuclear localizing signals (NLS) on the
is not related to the catalytic subunits (Rothwarf and NF-B subunits by the IB proteins. Thus, IB degrada-
Karin, 1999). Gel filtration analysis indicates that IKK is tion would simply lead to unmasking of the NLS, allowing
a large complex, 700–900 kDa in size, suggesting the free NF-B dimers to enter the classical nuclear import
presence of additional components. Recently, Cdc37 and pathway. However, a number of recent studies question
Hsp90 were suggested to serve as additional compo- the accuracy or generality of this simple model.
nents of the IKK complex (Chen et al., 2002). The func- The first set of such reports demonstrated that follow-
tional importance of these proteins to IKK was sug- ing NF-B activation, newly synthesized IBmolecules
gested by treating cells with geldanamycin (GA), an enter the nucleus and remove NF-B from DNA (Aren-
antitumor agent that interferes with the function of
zana-Seisdedos et al., 1995; Brown et al., 1993; Chiao
Hsp90. Such treatment reduced the size of the IKK com-
et al., 1994; Sun et al., 1993). The discovery that IB
plex and abolished TNF-induced activation of IKK and
contained leucine-rich nuclear-export sequences (NES)
NF-B. However, GA was not reported to inhibit other
supported the idea that newly synthesized IB trans-modes of IKK activation, and Hsp90 is known to be
ports NF-B back to the cytoplasm (Arenzana-Seis-associated with many protein kinases (Fisher et al.,
dedos et al., 1997; Rodriguez et al., 1999). However, an2000; Goes and Martin, 2001; Sato et al., 2000). In an-
NES was not found in IB (Malek et al., 2001; Tam andother study, geldanamycin was shown to cause the deg-
Sen, 2001), which through gene replacement experi-radation of another kinase associated with Hsp90 called
ments was shown to be functionally equivalent to IBRIP (Lewis et al., 2000). Knockout studies have shown
(Cheng et al., 1998). Furthermore, the mechanism re-that RIP is essential for TNF-induced NF-B activation
sponsible for nuclear uptake of IB remained contro-(Kelliher et al., 1998). Thus, it is not clear whether Hsp90
versial. One study suggested the action of a nonclassicalis a functional component of IKK or simply associated
NLS within the second ankyrin repeat of IB (Sachdevwith many kinases, some of which happen to be required
et al., 1998), whereas another report suggested a “piggy-for TNF signaling. In vitro, IKK and IKK exhibit similar
back” mechanism through which IB used the NLS ofsubstrate specificities, targeting two specific serines in
an associated protein (Turpin et al., 1999). A more likelythe N-terminal regulatory domain of IB proteins (Zandi
explanation for the nuclear uptake of NF-B:IB com-et al., 1997). However, IKK is a more potent IB kinase
plexes is the incomplete masking of the p50 NLS asthan IKK. By and large, the same major stimuli that
described below (Malek et al., 2001). The story becameactivate NF-B, including byproducts of microbial, fun-
more complex when CRM1, a key mediator of nucleargal, and viral infections and proinflammatory cytokines,
export, and leptomycin B (LMB), a specific CRM1 inhibi-also activate IKK, and thus, as we shall discuss below,
tor, were identified (Ossareh-Nazari et al., 1997). Al-IKK activity is absolutely essential for NF-B activation.
though the NES found in IB was located near its CPhosphorylation of IBs by IKK tags them for polyubi-
terminus, subsequent analysis suggested that a diver-quitination by a specific ubiquitin ligase belonging to
gent NES located near the N terminus (between aminothe SCF (Skp-1/Cul/F box) family (Ben-Neriah, 2002).
acids 45 and 55) was the functional motif (Huang et al.,The actual recognition of N-terminally phosphorylated
2000; Johnson et al., 1999; Tam et al., 2000). Remark-IBs is carried out by a WD repeat- and F box-containing
protein called -TrCP (Ben-Neriah, 2002). Upon ubiquiti- ably, treatment of unstimulated cells with LMB resulted
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Figure 1. A Model Depicting the Differential
Regulation of IB and IB Complexes
IB-containing complexes appear to contin-
uously shuttle in an out of the nucleus al-
though their default location is the cytosol.
IB complexes are exclusively cytosolic.
in almost complete redistribution of NF-B:IB com- nucleus (M.K., unpublished observations). Second, IB
degradation is blocked in LMB-treated cells, where theplexes to the nucleus, suggesting that these complexes
continuously shuttle in and out of the nucleus (Huang NF-B:IB complex was exclusively nuclear (Rodri-
guez et al., 1999). However, other studies suggest thatet al., 2000; Johnson et al., 1999; Rodriguez et al., 1999;
Tam et al., 2000). However, the default location for this the lack of IB degradation in LMB-treated cells re-
sulted from long periods of incubation with the inhibitor,complex is the cytoplasm because the effect of the NES
is dominant over that of the NLS (Figure 1). Moreover, and that in cells treated for shorter times, IL-1 and TNF
stimulation induced the degradation of nuclear IB (Re-nuclear export of NF-B:IB complexes may be en-
hanced by the presence of an additional NES on p65 nard et al., 2000). While this discrepancy remains to be
resolved, additional support for nuclear degradation of(Harhaj and Sun, 1999). Although the existence of a
potential NLS on IB itself remains to be validated, the IBwas obtained from a different source. As described
above, phosphorylated IB is recognized by -TrCP.crystallographic structure of a p50:p65:IB complex
provides a possible explanation for the nuclear entry This receptor protein targets the phosphorylated IB
for ubiquitination by coupling with the Skp1-Cul-Rocof these complexes (Huxford et al., 1998; Jacobs and
Harrison, 1998; Malek et al., 2001). This structure reveals ubiquitin ligase complex (Ben-Neriah, 2002). Although
IBphosphorylation is assumed to occur in the cytosol,that IB can mask only the NLS on p65, while the NLS
of p50 remains exposed. It is not surprising, therefore, -TrCP is quite unexpectedly exclusively localized in
the nucleus (Figure 1; Davis et al., 2002). The nuclearthat the NF-B:IB complex efficiently enters the nu-
cleus but is immediately expelled as a result of potent localization of -TrCP appears to be via its association
with hn-RNP-U, an abundant ribonucleoprotein that mayNES signals on IB and p65.
If the NF-B:IB complex indeed shuttles in and out serve as a pseudosubstrate for the ubiquitin ligase. Most
likely, the interaction between -TrCP and hnRNP-U isof the nucleus, the paradigm of cytoplasm to nuclear
translocation would still be maintained if the steps lead- out-competed by phosphorylated IB, suggesting that
IB ubiquitination takes place in the nucleus beforeing to IB phosphorylation and degradation occurred
exclusively in the cytosol. Several findings support this undergoing proteasome-mediated degradation (Davis
et al., 2002). Whether degradation occurs in the nucleusnotion. First, the IKK complex is almost exclusively cyto-
plasmic, with only small amounts of IKK present in the via nuclear proteasomes or whether the ubiquitinated
Cell
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NF-B:IB is reexported back to the cytosol has yet from the work of Scheidereit and colleagues who dem-
onstrated inducible phosphorylation of p65 followingto be determined.
cellular stimulation (Naumann and Scheidereit, 1994;The multiplicity of reports from numerous laboratories
Neumann et al., 1995). Most Rel proteins have a consen-that demonstrate a dynamic shuttling of NF-B:IB
sus recognition site (RRXS) for cyclic AMP-dependentcomplexes provides certain confidence that at least
protein kinase (PKA) located around 25 amino acidssome aspects of the model are likely to be valid. How-
upstream to their NLS within the RHD, suggesting thatever, these findings invite the more important question
PKA-mediated phosphorylation of NF-B might be in-of why this shuttling occurs in unstimulated cells. What
volved in both its inducible and constitutive activationadvantage is gained by this process in ensuring the
(Mosialos and Gilmore, 1993; Neumann et al., 1995). Ininducible activity of NF-B? While the presence of an
addition, phosphorylation of recombinant p65:p65 ho-effective NES on IB is fully consistent with its role in
modimers and p65:p50 heterodimers by PKA enhancedpostinduction inactivation of NF-B, having the nuclear
their DNA binding activity (Mosialos and Gilmore, 1993;NF-B:IB complex serve as a substrate for inducible
Neumann et al., 1995).ubiquitination and degradation seems difficult to com-
The importance of the PKA phosphorylation site inprehend from a biological standpoint (Figure 1). In par-
p65 at S276 was underscored by copurification of theticular, this process would appear to eliminate the regu-
PKA catalytic subunit (PKAc) with cytosolic NF-B:IBlation that is imposed by physical partitioning of the
complexes (Zhong et al., 1997). The PKAc bound toactive transcription factor from the inactive cytosolic
NF-B:IB complexes was found to be inactive, but itpool. It is important to note, however, that nearly all of
could be activated following IB degradation. The acti-the studies on the shuttling of NF-B:IB complexes
vated PKAc most likely phosphorylates p65 at S276 afterdepend on the use of LMB and that different biochemical
its activation, although it was also reported that in someapproaches have failed to detect nuclear NF-B:IB
cell types cytosolic p65 is constitutively phosphorylatedcomplexes in nonstimulated cells. Therefore, a valid
on S276, suggesting that phosphorylation might occurconcern is that the observed effects are due to an arti-
during assembly of the NF-B-IB-PKAc complex (An-factual unmasking of the NLS or some other problems
rather et al., 1999). The role of this phosphorylation ap-associated with the use of LMB.
pears to be 2-fold. First, it is necessary for enhancingBased on these studies, should we discard the original
DNA binding by p65; and second, it provides an addi-hypothesis that NF-B activation requires nuclear im-
tional interaction site for the transcriptional coactivatorport of free NF-B following phosphorylation-induced
CBP/p300 (Zhong et al., 1998, 2002). Before phosphory-IB degradation in the cytosol? The answer is not en-
lation, the C-terminal region of p65 interacts with thetirely. While IB is the major isoform being studied by
RHD, thereby interfering with both DNA and CBP/p300the vast majority of workers in the field, in many cells
binding. Phosphorylation of S276 prevents this intramo-nearly half of the NF-B is sequestered by the other
lecular association, thereby facilitating both DNA bind-major IB isoform, IB (Whiteside et al., 1997). The
ing and transcriptional activity of NF-B.genetic experiments mentioned above indicate that
A number of recent studies lend support to the pro-IB can fully replace IB (Cheng et al., 1998). IB,
posal that p65 phosphorylation may be necessary forhowever, does not possess a NES and its subcellular
transcriptional competence of nuclear NF-B (Bird etlocalization is not altered by LMB (Malek et al., 2001;
al., 1997; Madrid et al., 2000, 2001; Wang et al., 2000).Tam and Sen, 2001). Furthermore, unlike IB, IB
In addition to PKA, protein kinases such as casein kinaseefficiently masks the NLSs on both Rel subunits of
II, PKC, and IKK itself have been implicated in thisNF-B complexes. Therefore, IB-containing com-
process (Leitges et al., 2001; Wang et al., 2000). Theplexes are unable to shuttle under normal conditions
relative importance of each of these kinases in NF-Bsince they lack a free NLS (Figure 1). The potential func-
activation is yet to be determined, but the conclusion
tional equivalence between IB and IBmakes it diffi-
from these separate studies is that posttranslational
cult to assign a critical role for nuclear shuttling of
modification of p65 is critical for regulating NF-B tran-
NF-B:IB complexes in the normal regulation of scriptional activity. In addition, knockouts of the serine-
NF-B activity. Therefore, at this stage of analysis, it threonine protein kinases GSK3 and Tbk/t2k/NAK also
would be fair to conclude that while nuclear shuttling revealed dramatic effects on the transcriptional activity
of NF-B:IB complexes clearly occurs, the biological of NF-B (Bonnard et al., 2000; Hoeflich et al., 2000;
significance of this process remains to be established. Tojima et al., 2000). Cells from mice lacking either kinase
demonstrated normal activation of NF-B in response
How Important Is Regulation of Nuclear NF-B to a wide variety of inducers when measured by IB
Transcriptional Activity? degradation, NF-B nuclear translocation, or binding to
If the major step regulating NF-B activity is removal of DNA. But in both instances, nuclear NF-B was unable
IB from NF-B:IB complexes, it could be argued that to drive transcription. These results suggest that the
the control of IB degradation via IKK-mediated phos- embryonic lethality in these knockout strains caused by
phorylation is the most important point of regulation for massive hepatocyte apoptosis, a phenotype identical
the entire pathway. However, the regulation of NF-B to that observed in mice lacking either p65 or IKK (Beg
activation does not rely entirely on IKK, and recent stud- et al., 1995; Li et al., 1999b, 1999d; Tanaka et al., 1999),
ies have indicated that the capacity of nuclear NF-B is due to defective activation of NF-B-regulated
to drive transcription is also a regulated process. antiapoptosis genes. More recently, deletion of the
The first suggestion that some NF-B/Rel proteins, NF-B-inducing kinase (NIK) resulted in an unexpected
effect on NF-B transcriptional activity (Yin et al., 2001).particularly p65, are posttranslationally regulated came
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IKK has been shown in transient transfection experi-
ments to phosphorylate p65 at S536. The one complication
in this model is that direct biochemical analysis failed to
reveal IKK activation by Akt (Delhase et al., 2000).
The possible involvement of so many different kinases
in controlling p65 transcriptional activity seems unusual.
It is not clear whether these kinases lie in a linear path-
way that leads to a single phosphorylation site in p65
or whether they all target distinct sites on p65 (Figure
2). If the latter hypothesis is true, then do the different
p65 kinases respond to certain inducers but not others?
Also, for PKA and CKII, which are both thought to associ-Figure 2. A Depiction of the Different Protein Kinases that Have
Been Implicated in the Regulation of NF-B Transcriptional Activity ate with NF-B:IB complexes, what fraction of the cel-
lular pool of the latter is associated with each kinase?Protein kinase A catalytic subunit (PKAc) and casein kinase II (CKII)
have been shown to be directly associated with the cytosolic Finally, almost nothing is known about how GSK3 and
NF-B:IB complex, whereas the involvement of PKC, GSK3, TBK/t2k/NAK might influence NF-B transcriptional ac-
TBK/t2k/NAK, and NIK have been deduced from knockout studies. tivity and, as mentioned above, they or other kinases
may also act via other transcription factors. It seems
that a crucial experiment that would at least help answerUnlike GSK3/ and tbk/NAK/t2k/ mice, NIK/ mice
some of these questions would be to determine whetherare viable but cells derived from them fail to generate
these kinases can directly phosphorylate p65 and thentranscriptionally active NF-B in response to lympho-
mutate the putative phosphoacceptor sites for thesetoxin  (LT). Surprisingly, the response to many other
kinases. Preferably, the mutant alleles should be createdNF-B inducers is normal, suggesting NIK may play an
in mice using a knockin strategy. Recently, a similarimportant role in the transcriptional activation of nuclear
approach helped to establish the function of the putativeNF-B, but only in the context of LT signaling. While
activating phosphorylation sites on IKK (Cao et al., 2001).the participation of NIK in p100 processing to p52 might
One possible explanation for the critical role of p65partially explain the lowered transcriptional activity (dis-
phosphorylation is that it serves to recruit histone acetylcussed below), the level of nuclear NF-B complexes
transferases (HATs) to nuclear NF-B. Multiple studiesappears quite normal, suggesting that transcriptional
implicated both CBP/p300 and p/CAF HATS in NF-Bcompetence of these nuclear complexes is also affected
regulation (Gerritsen et al., 1997; Merika et al., 1998;(Yin et al., 2001). Recently it was suggested that although
Perkins et al., 1997; Sheppard et al., 1999; Zhong etIKK is not required for IB degradation and induction
al., 1998), and it is therefore not surprising that recentof NF-B DNA binding activity, it is required for genera-
findings have begun to demonstrate roles for histonetion of transcriptionally competent NF-B (Sizemore et
deacetylases (HDACs) as well. It was shown that p65al., 2002). As NIK is thought to act upstream to IKK in
can interact with distinct HDAC isoforms and that these
the processing pathway (Senftleben et al., 2001a), it is
interactions negatively regulate gene expression (Ash-
possible that the effect of NIK on NF-B transcriptional
burner et al., 2001; Chen et al., 2001; Ito et al., 2000;
activity is mediated through IKK (Figure 2). The deletion
Lee et al., 2000; Zhong et al., 2002). It is unclear, how-
of the atypical protein kinase PKC also had a significant ever, which HDAC isoform associates with p65. One
effect on the transcriptional activity of NF-B, but only report demonstrated that HDAC1 and HDAC2 (via bind-
in embryonic fibroblasts (Leitges et al., 2001). In other ing to HDAC1) associate with p65, when tested by immu-
tissues, such as lung, lack of PKC also affected the noprecipitation of endogenous HDACs from cells stably
activation of IKK, suggesting that it might serve different transfected with p65 (Ashburner et al., 2001). Two other
roles in different tissues (Leitges et al., 2001). However, studies reported association of endogenous HDAC1
similar to NIK, the ability to PKC to affect the activity with endogenous p65 in immunoprecipitation analysis
of IKK raises the possibility that the effect of PKC on the (Chen et al., 2001; Zhong et al., 2002). In GST pull-down
transcriptional activity of NF-B might also be mediated assays, both HDAC1 and HDAC2 were found to associ-
through IKK (Figure 2). ate with the p65-HAT complex (Ito et al., 2000; Lee et
Stimulation of cells by TNF has also been shown to al., 2000). Intriguingly, however, a more recent report
result in inducible p65 phosphorylation at position 529, demonstrates that TNF-induced, p300-dependent
which is mediated by casein kinase II (CKII) (Wang et acetylation of p65 is reversed by HDAC3 recruitment
al., 2000). The mechanism by which p65 phosphorylation (Chen et al., 2001). According to this model, acetylation
by CKII is regulated is similar to that proposed for PKA. of p65 determines the efficiency of its interaction with
CKII is constitutively active in most cells, but its ability IB. Therefore, the acetylated p65 that enters the nu-
to phosphorylate p65 is blocked by association with cleus is refractory to inhibition by IB, but following
IB. IB degradation relieves this repression, en- HDAC3 recruitment, the deacetylated p65 associates
abling inducible phosphorylation of p65. More recently, with IB and is exported to the cytoplasm, downregu-
phosphatidyl-inositol-3 kinase (PI3K) and Akt were also lating NF-B activity. These findings are consistent with
suggested to affect the transcriptional activity of p65 in prior observations regarding IB-mediated downregu-
response to IL-1 stimulation (Madrid et al., 2000, 2001). lation of nuclear NF-B and could represent a generally
However, neither PI3K nor Akt seems to directly phos- applicable mechanism for regulating association of pro-
phorylate p65; instead, PI3K-activated Akt activates teins in the nucleus. However, the effect of HDAC3 on
acetylated histones associated with promoters of p65IKK, which then phosphorylates p65 at S536. Notably,
Cell
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target genes was not examined, and the possibility that cell stimulation would be transcriptionally active and
HDAC3 could be replaced by other HDAC isoforms was capable of driving gene expression.
not directly tested (Chen et al., 2001). Therefore, it is
unclear if the observed effects are specific for HDAC3. Regulation of IKK Activity: How Is the IKK
Moreover, the level of acetylated p65 was very low, Complex Activated?
suggesting that the entire complement of nuclear p65 It can be argued that of all the different steps involved
might not be acetylated and hence, the scope of the in NF-B activation and modulation of its transcriptional
effects of HDAC3 would be limited. Consequently, the activity, the most critical one is the translocation of
major stimulatory effect of CBP/p300 on NF-B- NF-B dimers (mostly p50:p65 and p50:c-Rel) to the
dependent transcription might still be through acetyla- nucleus. Without entering the nucleus, NF-B cannot
tion of histones or other proteins in the chromatin- regulate transcription, and all other aspects of NF-B
remodeling machineries, and the inactivating effects of regulation become irrelevant. Nevertheless, it is impor-
deacetylation may predominantly target acetylated tant to realize that not all NF-B dimers are regulated
chromatin components and be carried out by multiple alike. For instance, as described above, some NF-B
HDAC isoforms. dimers are constitutively nuclear in nonstimulated cells,
The most abundant form of NF-B in cells is the where they may serve as transcriptional repressors.
p50:p65 heterodimer, although low levels of other family Also, the nuclear entry of p50:p65 and p50:cRel dimers
members have been identified in the nuclei of unstimu- are regulated differently from that of p52:RelB dimers.
lated cells. In particular, homodimers of p50 which lack In general, inducible nuclear entry is a highly regulated
a transactivation domain can be readily detected in rest- process requiring the coordinated action of more than
ing cell nuclei (Kang et al., 1992; Ten et al., 1992). Intrigu- three dozen different proteins (Karin and Ben-Neriah,
ingly, although p50 cannot recruit HATs directly, it can 2000). However, with the exception of the IB kinase
promote transcription in vitro via its ability to interact (IKK), whose activity is highly regulated, all of these
with other nuclear proteins, including Bcl-3, that recruit proteins are either constitutively active or lack enzy-
associated HATs (such as Tip60) (Dechend et al., 1999). matic activity. Therefore, the understanding of NF-B
However, several lines of evidence demonstrate that regulation and function is tightly linked to the under-
overexpression of p50 or enhanced DNA binding by standing of IKK regulation and function.
p50 causes decreased expression of NF-B-dependent Gene-targeting experiments have clearly demon-
genes (Ledebur and Parks, 1995; Plaksin et al., 1993). strated that the IKK and IKK subunits of IKK are re-
Furthermore, genetic defects that eliminate p50-DNA quired for NF-B activation by all known proinflamma-
binding release such suppression and enhance gene tory stimuli, including bacterial lipopolysaccharide
expression (Udalova et al., 2000). It has been assumed (LPS), negative-strand RNA viruses, double-stranded
that these repressive effects occur through competition (ds)RNA, immunostimulatory DNA sequences (ISS-
for DNA binding with complexes containing transactivat- DNA), TNF, IL-1, and antigens (Chu et al., 2000; Li et
ing NF-B proteins such as p65. However, this is an al., 1999b, 1999d; Makris et al., 2000; Rudolph et al.,
unlikely explanation as the affinity of p50 homodimers
2000; Schmidt-Supprian et al., 2000; Senftleben et al.,
for classical B site DNA is significantly lower than that
2001b; Tanaka et al., 1999). All of these stimuli lead
of NF-B heterodimers such as p50:p65 (Phelps et al.,
to IKK activation, whose kinetics and magnitude are
2000). It therefore appears that an alternative mecha-
directly related to those of NF-B activation. However,nism accounts for the ability of p50 (that is capable of
the intriguing question of how these diverse stimuli con-transactivation in vitro) to repress B-dependent gene
verge to activate a single signaling enzyme remains forexpression.
the most part unanswered. Although the complex mech-One potential mechanism underlying transcriptional
anistic details regarding IKK activation are still beingrepression by p50 homodimers is the recruitment of
unraveled, most of the currently available results thatcorepressor complexes containing specific HDACs to
have been verified genetically point to one generalthe promoter regions of B-dependent genes. This hy-
mechanism requiring IKK phosphorylation.pothesis received attention recently, and it has now
Both IKKand IKKcan be produced as active recom-been shown that the complement of nuclear NF-B com-
binant proteins using baculovirus or yeast expressionplexes in unstimulated cells consists primarily of p50
systems (Miller and Zandi, 2001; Zandi et al., 1998).homodimers associated with HDAC-1 (Zhong et al.,
However, in mammalian cells, their activation depends2002). The ability of such p50:HDAC-1 complexes to
on association with the IKK regulatory subunit (Makrisrepress gene expression was demonstrated using the
et al., 2000; Rothwarf and Karin, 1999; Yamaoka et al.,specific HDAC-inhibitor trichostatin A (TSA) that upregu-
1998). The activity of IKK and IKK also depends onlated expression of a subset of B-dependent genes in
their ability to dimerize via their leucine zipper motifswild-type but not p50/ cells (Zhong et al., 2002). These
(Mercurio et al., 1997; Woronicz et al., 1997; Zandi et al.,studies also demonstrated that following cell stimula-
1997). Once IKK and IKK dimerize, they can associatetion, NF-B complexes comprising p50 associated with
with IKK through a short interaction motif located atp65 that was phosphorylated in the cytoplasm by PKAc,
the very C terminus of either catalytic subunit (Hu et al.,enter the nucleus, and displace the p50:HDAC-1 com-
2001; May et al., 2000). Short peptide mimics of thisplexes from B sites within certain target gene promot-
interaction motif can be used to disrupt the IKK complexers. These findings may therefore provide a reason for
and prevent its activation (May et al., 2000). The associa-the added layer of regulation imposed by phosphoryla-
tion of IKK and IKK dimers (usually IKK:IKK hetero-tion of p65, as such a process would ensure that only
NF-B heterodimers present in the nucleus following dimers) with IKK results in formation of a large complex,
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composed of IKK:IKK heterodimers held together via signals activate IKK via IKK, while the majority of proin-
flammatory stimuli target IKK through the IKK subunit.dimeric interactions between two IKKmolecules (Miller
and Zandi, 2001; Rothwarf and Karin, 1999). At this point, Exactly how any given signaling pathway targets the
IKK complex is still a matter of debate. It has beenit is not clear whether different cell types contain IKK
complexes of different composition of IKK and IKK suggested that cell stimulation with TNF results in re-
cruitment of IKK complexes to the type 1 TNF receptorsubunits. Nevertheless, complex assembly is essential
for stimulus-dependent IKK activation (Rothwarf and (TNFR1) signaling complex (Devin et al., 2000; Zhang
et al., 2000). Although the amount of recruited IKK isKarin, 1999). In addition to its role in complex assembly,
IKK serves an important regulatory function by con- relatively small, it may be sufficient to activate the re-
mainder of the IKK pool via IKK-mediated transauto-necting IKK to upstream activators through its C termi-
nus, which contains a Zn finger motif. Truncation of phosphorylation. Both IKK and IKK are efficiently
autophosphorylated within the activation loop whenthe IKK C terminus or single amino acid substitutions
within it do not affect assembly of the large IKK holoen- overexpressed, and this autophosphorylation is re-
quired for their activation (Miller and Zandi, 2001; Zandizyme but do compromise its activation (Rothwarf and
Karin, 1999). Certain IKK and NF-B activators, such as et al., 1998). Gene-targeting experiments have estab-
lished the involvement of several components of thethe Tax protein of HTLV-1, were proposed to act by
directly contacting IKK (Carter et al., 2001). TNFR1 signaling complex, the protein kinase RIP1 and
two interchangeable TRAF proteins, TRAF2 and TRAF5Apart from assembly of this large IKK holocomplex,
activation of IKK by all proinflammatory and innate im- (Devin et al., 2000; Kelliher et al., 1998; Tada et al.,
2001), in IKK activation. It was proposed that TRAF2mune stimuli depends on phosphorylation of either the
IKKor IKK catalytic subunits at two conserved serines (and presumably TRAF5) recruit the IKK complex to the
receptor, whereas RIP1 is responsible for IKK activationlocated within their activation loops (Delhase et al., 1999;
Ling et al., 1998; Mercurio et al., 1997). Regulation of (Devin et al., 2000). However, there is disagreement as
to how this recruitment is achieved. While Zhang et al.protein kinase activity through phosphorylation of spe-
cific sites within the activation loop is a very common (2000) showed that IKK recruited the IKK complex to
RIP after TNF stimulation, Devin et al. (2000) suggestedmechanism (Taylor et al., 1995). Such phosphorylation
may be achieved either through the action of an up- that recruitment is mediated via the IKK catalytic sub-
units. Although IKKand especially its C terminus seemsstream kinase or through transautophosphorylation
brought about by induced proximity between two cata- to be the logical mediator of IKK recruitment, so far no
direct interactions between IKK and any componentlytic subunits within the same complex. The latter mech-
anism may be more evolutionarily ancient. of signaling complexes assembled at TNF or IL-1 re-
ceptors were detected. It is possible, however, that uponCell stimulation with either TNF or IL-1 rapidly in-
creases IKK and IKK phosphorylation (Delhase et al., IKK recruitment to the receptor, the C terminus of IKK
is modified and that this modification somehow triggers1999). In the case of IKK, the first sites to be phosphory-
lated are the activation loop serines, whose replacement IKK activation. Surprisingly, the kinase activity of RIP1
is dispensable for IKK activation, suggesting that RIP1with alanines generates a mutant form of IKK that,
when incorporated into IKK holocomplexes, prevents most likely acts through protein-protein interactions ei-
ther with IKK or a yet-to-be identified IKK kinase. Aactivation in response to TNF, IL-1, or LPS (Delhase
et al., 1999). Curiously, the substitution of the same two similar signaling mechanism is probably used by IL-1
and similar to RIP1, the kinase activity of the IL-1 recep-serines in the IKK activation loop, whose sequence is
almost identical to that of IKK, did not interfere with tor-associated kinase 1 (IRAK1) is not required for IKK
activation (Li et al., 1999c).activation of the IKK holocomplex assembled around
the mutant IKKAA form in response to either TNF or Within the emerging paradigm of protein kinases that
also function as adapters, another protein kinase in-IL-1 (Cao et al., 2001; Delhase et al., 1999). Similar results
were obtained using catalytically inactive (defective in volved in IKK activation is PKR, which is required for
the response to dsRNA and viral infection (Chu et al.,ATP binding) mutants of IKK and IKK. These findings
provided the first clue to the functional heterogeneity 1999). Interestingly, catalytically inactive PKR is as ca-
pable of activating IKK as the wild-type form (Bonnetof IKK and IKK. Gene targeting experiments (Li et al.,
1999b, 1999d; Takeda et al., 1999; Tanaka et al., 1999) et al., 2000; Chu et al., 1999). It was proposed that PKR
activates IKK through direct protein-protein interaction,verified that IKK, and not IKK, is the subunit required
for IKK (and NF-B) activation by proinflammatory stim- possibly via the IKK subunit (Bonnet et al., 2000). Inter-
estingly, PKR is also required for NF-B activation byuli. It is now evident that although it is dispensable for
IKK activation in response to proinflammatory stimuli, LPS from gram-negative (GN) bacteria (Goh et al., 2000).
Instead of IRAK, the GN LPS signal that is generatedIKK is essential for IKK activation by a set of signals
that do not affect the IKK subunit (Cao et al., 2001). via Toll-like receptor (TLR) 4 is transduced through the
adaptor protein TIRAP/MAL (Fitzgerald et al., 2001;Mammary epithelial cells and B lymphocytes that ex-
press the IKKAA form instead of the wt protein exhibit Horng et al., 2001). In that case, PKR may play a role
analogous to the one played by IRAK in the case ofdefective IKK (and NF-B) activation in response to two
members of the TNF cytokine family: RANK (receptor IL1R and TLR2/6 signaling. dsRNA also acts via TLR3
(Alexopoulou et al., 2001). TLR3 signaling is dependentactivator of NF-B)-ligand (RANKL) and B lymphocyte
stimulator (Blys/BAFF), respectively (Cao et al., 2001). on MyD88, as is the response mediated by TLR9, which
is responsible for IKK and NF-B activation by ISS-DNABy contrast, IKK complexes that contain the IKKAA sub-
unit but still contain wt IKK display normal responses (Hemmi et al., 2000). Curiously, the response to ISS-
DNA also requires the DNA-dependent protein kinase,to TNF, IL-1, and LPS (Cao et al., 2001). Thus, certain
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DNA-PK (Chu et al., 2000). However, the relationships (Ruland et al., 2001), and coexpression of MALT1 facili-
between TLR9 signaling and DNA-PK activation are not tates Bcl10-mediated NF-B activation (Lucas et al.,
clear, but it is possible that DNA-PK may play an analo- 2001). MALT1 is a paracaspase that contains a CARD
gous role to PKR. domain known to be involved in aggregation-induced
Besides the kinases described above, recent studies activation. Despite the similarity in phenotypes and
have indicated a surprising role for ubiquitination and function, the exact mechanistic relationships between
the MAP3 kinase TAK1 in the activation of the IKK com- PKC, Bcl10, MALT1, and IKK remain to be elucidated.
plex (Deng et al., 2000; Wang et al., 2001). Using an in Although the substrate for PKC in this signaling cas-
vitro system, it was found that activation of the IB cade needs to be identified, it should be noted that
kinase complex by TRAF6 required two biochemically unlike many of the protein kinases discussed above,
purified activities, TRIKA1 and TRIKA2. While TRIKA1 catalytically inactive PKC is incapable of activating
consists of the ubiquitination proteins Ubc13 and NF-B (Khoshnan et al., 2000).
Uev1A, TRIKA2 consists of TAK1 and two other associ- An important issue that is yet to be resolved is the
ated proteins, TAB1 and TAB2. Biochemical analysis exact role of IKK. Undoubtedly, IKK is essential to
suggested that nonclassical ubiquitination of TRAF6 on IKK activation. It is also clear that in addition to its role
lysine 63 by Ubc13 and Uev1A led to its activation, and in IKK holoenzyme assembly, IKKplays a critical signal-
such ubiquitinated TRAF6 could then activate the TAK1 ing role. An attractive hypothesis, mentioned above, is
complex. The activated TAK1 subsequently activates that IKK directly interacts with distinct IKK activators.
MKK6 and IKK, thereby turning on both the JNK and Thus, several groups have undertaken the task of identi-
NF-B pathways. Although these studies are provoca- fying IKK-interacting proteins, and in addition to IKK
tive and suggest a potentially novel role for ubiquitina- and IKK, this approach has resulted in the identification
tion in the NF-B signaling pathway, all of the evidence of a small number of potential IKK binding proteins
presented to date rely on in vitro or overexpression (Hong et al., 2001; Leonardi et al., 2000). Unfortunately,
analysis, and genetic evidence for such regulatory pro- however, the physiological function of any of these pro-
cesses is still lacking. teins is not yet known. Another possibility that needs to
It is plausible that PKR, IRAK1, and RIP1 activate IKK be examined is whether IKK itself serves as a target for
directly via an induced proximity mechanism in which regulated phosphorylation (Carter et al., 2001). Although
a dimer or a higher oligomer of the activator contacts TNF stimulation results in increased IKKphosphoryla-
each IKK/IKK dimer, increasing their proximity within tion, the location of the phosphorylation sites and their
the higher order IKK complex, and thereby facilitating function remains to be determined. Even in the case
mutual transautophophorylation. In such a case, no IKK of IKK, where the role of phosphorylation has been
kinase is needed. Indeed, none of the putative IKK ki- determined, some of the observed phosphylation events
nases proposed so far, including NIK (Yin et al., 2001), have an activating role and some have an inhibitory role
NAK/T2K/TBK (Bonnard et al., 2000), MEKK1 (Xia et al., (Delhase et al., 1999).
2000; Yujiri et al., 2000), Cot/TPL2 (Dumitru et al., 2000),
and even the TAB2 component of the TAK1 signaling Why Does the IKK Complex Contain Two Catalytic
complex (S. Akira, personal communication), have with-
Kinase Subunits?
stood the gene disruption test—no effects on activation
The extensive structural similarity between the IKK and
of IKK or induction of NF-B DNA binding activity have
IKK catalytic subunits, their similar abilities to phos-been detected in mice lacking these kinases. One ex-
phorylate IB proteins and their heterodimerization sug-ception may be MEKK3, which is required for IKK activa-
gested that their functions are likely to be redundanttion in response to TNF in cells; however, the exact
and overlapping. However, the site-directed mutagene-mechanism by which it activates IKK remains to be es-
sis experiments discussed above suggest that IKK andtablished (Yang et al., 2001). Thus, until a role of IKK
IKK may have distinct regulatory functions. This possi-kinases is firmly established, the induced proximity
bility has been confirmed through the generation andmodel remains an attractive and logical possibility.
analysis of mutant mice that either lack specific IKKAnother protein kinase whose role in IKK or NF-B
subunits or express them as inactive forms.activation has been genetically confirmed is PKC (Sun
Disruption of the Ikk locus results in midembryonicet al., 2000). Although PKC/ mice are viable and ap-
lethality due to extensive liver apoptosis (Li et al., 1999b,parently normal, their peripheral T cells cannot be acti-
1999d; Tanaka et al., 1999), a phenotype very similar tovated in response to antigen due to a striking deficiency
that resulting from ablation of the RelA gene (Beg et al.,in NF-B activation (Sun et al., 2000). PKC, however,
1995). Most importantly, the lethality associated withis not a direct IKK activator, and it is possible that its
the loss of either IKK or p65/RelA is prevented byactivity requires two other proteins, Bcl10 and MALT1
ablation of TNFR1 (Alcamo et al., 2001; Li et al., 1999b,(Gaide et al., 2001; Lucas et al., 2001). Intriguingly, the
1999d; Senftleben et al., 2001b), indicating that it is TNFgenes encoding both of these proteins are affected by
mediated. These results provided a genetic proof thattwo different chromosomal translocations involved in
IKK is required for activation of p65/RelA-containingthe same type of mucosal-associated lymphoid tissue
NF-B dimers in liver cells and that these complexes(MALT) lymphoma. Such rearrangements result in over-
are in turn required for expression of antiapoptotic genesexpression of Bcl10 or MALT1 fusion proteins whose
whose products suppress TNF-induced apoptosis. Con-overexpression can lead to NF-B activation (Gaide et
gruently, IKK-deficient mouse fibroblasts display anal., 2001; Lucas et al., 2001; Uren et al., 2000). Impor-
NF-B activation defect not only in response to TNF, buttantly, Bcl10-deficient lymphocytes do not activate
NF-B in response to occupancy of antigen receptors also in response to IL-1, dsRNA, and ISS-DNA (Chu et al.,
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1999, 2000; Li et al., 1999b, 1999d; Tanaka et al., 1999). of Bcl-2 (Grossmann et al., 2000). Through these protec-
tive functions and by virtue of its requirement for NF-BFurthermore, IKK-deficient thymocytes exhibit defective
NF-B activation and highly attenuated proliferative re- activation, IKK is likely to be an important mediator of
inflammation. Experiments using conditional Ikk genesponse following ligation of the T cell receptor (Senft-
leben et al., 2001b). knockouts and specific IKK inhibitors are critically
needed for evaluating its role in chronic and acute in-Despite the absence of embryonic lethality and their
normal development, Ikk/Tnfr1/ double mutant flammatory diseases.
The initial analysis of Ikk null mice did not reveal anymice fail to thrive and die within 2–3 weeks after birth,
suffering from severe opportunistic infections (Senft- indication of the role of IKK in the regulation of NF-B
activity and immune responses. Instead, Ikk/ miceleben et al., 2001b). A similar immunodeficient pheno-
type is exhibited by RelA/Tnfr1/ double mutant mice, exhibited severe morphological abnormalities mostly at-
tributable to defective epidermal differentiation (Hu etalthough these mice survive for up to 2 months, due to
a higher level of residual NF-B activity (Alcamo et al., al., 2001; Li et al., 1999a; Takeda et al., 1999). However,
cells derived from IKK-deficient animals display normal2001). Tnfr1/ mice are not susceptible to such infec-
tions, indicating that the severe immunodeficiency is IKK activation in response to proinflammatory stimuli
and relatively normal induction of NF-B DNA bindingstrictly caused by reduced NF-B activity. Detailed anal-
ysis of RelA/Tnfr1/ mice revealed a defect in neutro- activity (Chu et al., 1999; Hu et al., 1999, 2001). Although
IKK performs an essential function in regulating kera-phil migration due to insufficient production of chemo-
kines and adhesion molecules by epithelial cells (Alcamo tinocyte differentiation, this does not depend on its pro-
tein kinase activity or its effect on NF-B (Hu et al.,et al., 2001). Adoptive transfer experiments demon-
strated that RelA/Tnfr1/ neutrophils exhibit normal 2001). Due to the early lethality associated with the com-
plete loss of IKK, adoptive transfer experiments weremigration, and reconstitution of RelA/Tnfr1/ mice
with normal myeloid and lymphoid cells did not alleviate required to reveal its important and unique function in
the lymphoid system, which depends on its protein ki-their susceptibility to infections (Alcamo et al., 2001).
Similar results were obtained in adoptive transfer experi- nase activity (Kaisho et al., 2001; Senftleben et al.,
2001a). Lethally irradiated mice reconstituted withments using either Ikk/ or Ikk/Tnfr1/ hematopoi-
etic stem cells (Senftleben et al., 2001b). Collectively Ikk/ hematopoietic stem cells demonstrate a marked
reduction in B cell maturation, antibody production, andthese experiments demonstrate that the IKK and p65/
RelA-containing NF-B dimers are required for activa- germinal center (GC) formation in response to T cell-
dependent antigens (Kaisho et al., 2001; Senftleben ettion of innate immune responses. Interestingly, the most
important innate immune functions of IKK and NF-B al., 2001a). The Ikk/ chimeras also display defective
splenic microarchitecture, absence of follicular dentriticare most likely exerted within the nonhematopoietic
compartment, probably in the epithelial cells of tissues, cells (FDC), and marginal zone macrophages (Kaisho
et al., 2001), as well as absence of Peyer’s patchessuch as lung, liver, and intestinal mucosa, which come
in contact with a variety of pathogens. Although the (Senftleben et al., 2001a). As yet, no overt defects in
T cell development or proliferation have been reportedgenes that mediate innate immunity remain to be identi-
fied, a likely possibility is that NF-B activation within for these mice (Kaisho et al., 2001; Senftleben et al.,
2001a). Thus, IKK seems to be specifically required forepithelial cells is required for expression of antimicrobial
peptides, such as the  defensins, that provide the first B cell-mediated responses and organization of lymphoid
organs.line of defense against microbial infections. In addition,
NF-B is required for the synthesis of chemokines and Does IKK exert its B cell-specific function through
regulation of NF-B? Interestingly, somewhat similar de-adhesion molecules, which are needed for recruitment
of professional bacteriocidal cells, such as macro- fects in B cell-mediated responses, GC formation and
splenic microarchitecture, were detected in Nfkb2/phages and neutrophils.
In addition to their undisputable function in activation mice (Caamano et al., 1998; Franzoso et al., 1998).
Nfkb1/ mice also show defective B cell-mediated re-of innate immune responses, IKK and p65/RelA are
required in lymphoid cells for suppression of apoptosis sponses but normal B cell maturation (Sha et al., 1995).
Similar defects but normal B cell development and matu-(Grossmann et al., 2000; Horwitz et al., 1997; Senftleben
et al., 2001b). Lethally irradiated mice reconstituted with ration are also exhibited by c-Rel/ mice (Kontgen et
al., 1995). Thus, it seems that the specific defect in B celleither Ikk/ or NFkB1//RelA/ hematopoietic stem
cells display almost complete absence of B and T lym- maturation and formation or organization of lymphoid
organs caused by the absence of IKK is unlikely tophocytes at various stages of development and a
marked increase in the number of monocytes and granu- reflect a general NF-B deficiency. Such a conclusion
is consistent with recent demonstration of defective in-locytes (Horwitz et al., 1997; Senftleben et al., 2001b).
However, analysis of Ikk/Tnfr1/ or RelA/Tnfr1/ duction of NF-B DNA binding activity in response to
LPS or anti-CD40 in Ikk/ B cells (Kaisho et al., 2001).newborn mice revealed either a partial decrease in the
number of lymphocytes or no decrease at all (Alcamo Despite that general defect, the same investigators
found relatively normal induction of at least one NF-Bet al., 2001; Senftleben et al., 2001b). Although NF-B
is not required for lymphocyte development per se, it is target gene, encoding the antiapoptotic molecule A1
(Kaisho et al., 2001). Indeed, other investigators de-required for suppressing lymphocyte apoptosis during
early development (Voll et al., 2000) or in response to tected induction of NF-B DNA binding activity in Ikk/
B cells (Senftleben et al., 2001a). In addition, the defec-TNF production (Senftleben et al., 2001b). NF-B may
also be required for reducing the rate of spontaneous tive maturation of Ikk/ B cells was shown not to be
due to increased sensitivity to apoptosis that is ex-apoptosis in mature B cells by elevating the expression
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Figure 3. A Model Indicating the Two Signal-
ing Pathways to NF-B
One pathway is the classical pathway medi-
ated by IKK and leading to phosphorylation
of IB. The other pathway involves IKK and
leads to the phosphorylation and processing
of p100, generating p52:RelB heterodimers.
pected in the case of a general NF-B deficiency, nor can it is unlikely that the classical IKK complex is involved in
NF-B2/p100 processing. Indeed, NIK-induced NF-B2/it be suppressed by ectopic Bcl-2 expression (Kaisho et
al., 2001). p100 processing is not affected by the absence of either
IKK or IKK (Senftleben et al., 2001a).Most intriguingly, instead of a general NF-B activa-
tion defect, Ikk/ B cells exhibit a specific deficiency Most likely, the processing of NF-B2/p100 depends
on a different IKK-containing complex that may alsoin NF-B2/p100 processing (Figure 3; Senftleben et al.,
2001a). Unlike the processing of NF-B1/p105, which contain NIK. It is noteworthy that, in addition to its bio-
chemical identification as a component of the IKK com-occurs constitutively and is normal in Ikk/ B cells,
the processing of NF-kB2/p100 is highly regulated and plex (DiDonato et al., 1997), IKK was also identified as
a NIK-interacting protein in a yeast two-hybrid screencan be induced in response to ectopic expression of
NIK (Xiao et al., 2001). Interestingly, the induction of (Regnier et al., 1997). Although it remains to be deter-
mined whether a complex containing both proteins actu-NF-B2/p100 processing by ectopic NIK is blocked by
the absence of IKK (Senftleben et al., 2001a), sug- ally exists, the NIK-IKK pathway seems to be specifi-
cally activated by the LT receptor (LTR), a member ofgesting that IKK acts downstream of NIK in a pathway
that controls NF-B2/p100 processing. Indeed, knockin the TNFR family. Preliminary results reveal that agonistic
anti-LTR antibodies can induce NF-B2/p100 pro-mice expressing the IKKAA variant, which lacks the acti-
vating phosphoacceptor sites that can be phosphory- cessing in an IKK-dependent manner. Furthermore, the
phenotype of LTR-deficient mice (Futterer et al., 1998)lated by NIK in vitro (Ling et al., 1998), also exhibit defec-
tive NF-B2/p100 processing, defective B cell maturation, is similar to that of Nikaly/aly (Fagarasan et al., 2000; Shin-
kura et al., 1999) or Nik/ (Yin et al., 2001) mice, all ofand defective lymphoid organ formation (Senftleben et
al., 2001a). These results suggest that IKK may be a which show extensive defects in lymphoid organ devel-
opment and organization that may be due in part tospecific target for NIK and that, once activated, it may
lead to phosphorylation-dependent processing of insufficient production of B lymphocyte chemoattrac-
tant (BLC) by stromal cells (Fagarasan et al., 2000). Inter-NF-B2/p100. Although in vitro studies have demon-
strated that IKK can phosphorylate NF-B2/p100 on estingly, both LT/(Ngo et al., 1999) and Nfkb2/ (Pol-
jak et al., 1999) mice fail to express BLC. Thus, we predictsites that are required for processing, this remains to
be shown in vivo. As both Ikk/ and IkkAA/AA B cells that BLC is encoded by a specific p52-dependent gene
whose production by stromal cells is required for organi-contain IKK complexes that can still be activated by LPS,
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zation of lymphoid organs. As LTR is expressed in defective expression of the NF-B-dependent gene
stromal cells rather than in B lymphocytes, and BLC is cyclin D1, which is required for proliferation of the mam-
a chemokine acting via a G protein-coupled receptor mary epithelium during pregnancy (Cao et al., 2001). In
that is unlikely to be a potent IKK activator, it appears this case, IKK may function as a component of the
that another receptor is likely to account for activation classical IKK complex that is specifically required for
of the putative NIK-IKK signaling complex and induc- its activation by RANKL but not TNF, IL-1, or LPS (Cao
tion of NF-B2/p100 processing in B cells. One possible et al., 2001). It remains to be determined, however,
candidate for this receptor is BAFF-R, a recently discov- whether IKK is required for other RANKL-regulated
ered Blys(BAFF) receptor, that is also a member of the processes, such as osteoclast and T cell differentiation
TNFR family (Thompson et al., 2001; Yan et al., 2001). (Kong et al., 1999).
Recent studies have demonstrated that mice lacking Unlike the situation in B cell development discussed
Blys or BAFF-R exhibit defective B cell maturation and above, it is not entirely clear what biological advantage
lymphoid organ organization similar to the Ikk/ chime- the functional separation of IKK- and IKK-dependent
ras (Schiemann et al., 2001; Thompson et al., 2001). NF-B signaling in mammary epithelial cells would pro-
Although not formally proven, indirect evidence sug- vide. As the mammary gland is a recent adaptation
gests that defective NF-B2/p100 processing is respon- unique to mammals, it is possible that this separation
sible for many of the defects in B cell maturation, hu- is simply due to recruitment of RANK signaling to the
moral immunity, and lymphoid organ development control of mammary gland development. Thus, the real
present in Ikk/ chimeras or Nik/ mice. First, similar cause for functional separation between IKK and IKK
defects are exhibited by Nfb2/ mice (Caamano et al., may lie within another cell type whose destiny depends
1998; Franzoso et al., 1998) that are also defective in on RANK signaling—the macrophage. It would be worth-
BLC production (Poljak et al., 1999). Second, expression while examining whether macrophage proliferation and
of NF-B2 is particularly high in mature B cells (Senft- activation are dependent on IKK, whereas macrophage
leben et al., 2001a). Third, mice that produce p52 consti- differentiation into more mature cell types depends on
tutively due to deletion of the 3	 portion of the Nfb2 RANK at IKK.
gene coding for the IB-like domain exhibit B cell hyper-
plasia and enlargement of spleen and lymph nodes (Ishi- Conclusions
kawa et al., 1997). Finally, chromosomal rearrangements Of the many unanswered questions concerning various
that detach p52 from the IB-like domain of p100 have aspects of NF-B regulation and function, we have high-
been detected in B cell lymphomas (Zhang et al., 1994). lighted here only a few areas for discussion. Other im-
It therefore appears that instead of playing a role in the portant questions that we were unable to cover include
canonical NF-B activation pathway initiated by proin- understanding the exact mechanism of p105 and p100
flammatory stimuli and involving phosphorylation and processing, defining the mechanism underlying tran-
degradation of IB proteins, IKK functions in a special- sient versus persistent NF-B activation, identifying the
ized pathway based on phosphorylation-dependent mechanisms involved in the termination of NF-B activa-
processing of NF-B2/p100 to p52.
tion, determining the role of modulators such as the B-
In contrast to its processing, the expression of p100
Ras proteins, and elucidating the mechanisms underly-
seems to be regulated by the canonical IKK-dependent
ing constitutive activation of NF-B in different tumors.
NF-B activation pathway, as NF-B2 has been identi-
However, the issues that we have highlighted, in ourfied as an NF-B target gene. Given the important role of
opinion, represent areas of current, active research, andNF-B2 in B cell biology, it is likely that the two separate
findings in these areas will contribute significantly to ourIKK- and IKK-dependent signaling pathways play a
further understanding of NF-B biology.central role in providing a molecular linkage between
We also have not discussed how different NF-B di-innate and adaptive immune responses. B cell stimula-
mers activate distinct sets of NF-B target genes, some-tion by LPS or via the antigen receptor may result in
thing that is suggested by the distinct phenotypes ofupregulation of p100 expression and activation of cer-
knockout mice lacking distinct NF-B subunits. It is alsotain NF-B target genes. In the absence of p100 pro-
not clear which of the target genes activated by p65/cessing, this may drive the expansion of antigen-spe-
RelA are most critical for the suppression of apoptosis.cific but immature B cells. Only within lymphoid organs,
As recently discussed, the exact mode by which NF-Bsuch as GCs and Peyer’s patches, would B cells be
inhibits apoptosis may vary from one cell type to anotherexposed to Blys, which is produced by macrophages.
(Karin and Lin, 2002). Despite the many remaining uncer-This would lead to their maturation and to the activation
tainties and questions, it has become apparent that theof processes such as class switching and affinity matu-
IKK complex plays a central role in regulation of NF-Bration.
activity and function. It is also clear that the unusualIKK is also required for induction of IB degradation
composition of IKK, with two distinct catalytic subunitsin response to certain stimuli, although it is not essential
and one regulatory subunit, is intimately related to itsfor the response to common proinflammatory stimuli. A
multifunctional role. The classical IKK complex, com-recent study demonstrated that IkkAA/AA mice exhibited
posed of IKK, IKK, and IKK, is required for nucleardefective development of the mammary gland during
translocation of NF-B heterodimers in response to apregnancy (Cao et al., 2001). This defect was attributed
diverse collection of stimuli. While responses to proin-to the inability of IkkAA/AA mammary epithelial cells to
flammatory stimuli, such as TNF, IL-1, LPS, and dsRNA,respond to RANKL with induction of classical NF-B
are largely dependent on the IKK catalytic subunit,DNA binding activity (p50:p65 heterodimers). Corre-
spondingly, IkkAA/AA mammary epithelial cells exhibit responses to other stimuli, such as RANKL and possibly
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Baldwin, A.S., Jr. (2001). Series introduction: the transcription factorBlys/BAFF or LT/, depend on the IKK catalytic sub-
NF-B and human disease. J. Clin. Invest. 107, 3–6.unit. Whereas IKK activation leads to nuclear translo-
Beg, A.A., Sha, W.C., Bronson, R.T., Ghosh, S., and Baltimore, D.cation of NF-B heterodimers by inducing IB phos-
(1995). Embryonic lethality and liver degeneration in mice lackingphorylation and degradation, the IKK subunit is
the RelA component of NF-B. Nature 376, 167–170.
involved in formation of another signaling module to-
Ben-Neriah, Y. (2002). Regulatory functions of ubiquitination in thegether with NIK that is required for processing of
immune system. Nat. Immunol. 3, 20–26.
NF-B1/p100. This module is specifically activated by
Bird, T.A., Schooley, K., Dower, S.K., Hagen, H., and Virca, G.D.
LT/ through the LTR and by Blys/BAFF through (1997). Activation of nuclear transcription factor NF-B by interleu-
BAFF-R. As NF-B2/p100 has an IB-like function and kin-1 is accompanied by casein kinase II-mediated phosphorylation
the basal level of processed p52 in nonstimulated cells of the p65 subunit. J. Biol. Chem. 272, 32606–32612.
is very low, it is likely that inducible NF-B2/p100 pro- Bonnard, M., Mirtsos, C., Suzuki, S., Graham, K., Huang, J., Ng,
M., Itie, A., Wakeham, A., Shahinian, A., Henzel, W.J., et al. (2000).cessing results in the nuclear translocation of specific
Deficiency of T2K leads to apoptotic liver degeneration and impairedp52-containing NF-B heterodimers, such as p52:RelB.
NF-B-dependent gene transcription. EMBO J. 19, 4976–4985.This processing-based pathway is likely to be responsi-
Bonnet, M.C., Weil, R., Dam, E., Hovanessian, A.G., and Meurs, E.F.ble for activation of a specific subset of NF-B target
(2000). PKR stimulates NF-B irrespective of its kinase function bygenes. This pathway is not involved in innate immunity
interacting with the IB kinase complex. Mol. Cell. Biol. 20, 4532–
or inflammation but instead plays a central role in medi- 4542.
ating cell-cell interactions that are critical for lymphoid Brown, K., Park, S., Kanno, T., Franzoso, G., and Siebenlist, U.
organ development. (1993). Mutual regulation of the transcriptional activator NF-B and
As is clear from this review, there is a lot that remains its inhibitor, IB-. Proc. Natl. Acad. Sci. USA 90, 2532–2536.
to be understood about regulation of NF-B. However, Caamano, J.H., Rizzo, C.A., Durham, S.K., Barton, D.S., Raventos-
Suarez, C., Snapper, C.M., and Bravo, R. (1998). Nuclear factor (NF)-we believe that the convergence of genetic and bio-
B2 (p100/p52) is required for normal splenic microarchitecture andchemical approaches that are being currently utilized
B cell-mediated immune responses. J. Exp. Med. 187, 185–196.will provide us with answers in the near future that will
Cao, Y., Bonizzi, G., Seagroves, T.N., Greten, F.R., Johnson, R.,shed light on many of the remaining mysteries of the
Schmidt, E.V., and Karin, M. (2001). IKK provides an essential linkmammalian NF-B system.
between RANK signaling and cyclin D1 expression during mammary
gland development. Cell 107, 763–775.
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